Mechanism of Fluconazole Resistance in Candida krusei

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736 · see citing works

The Carbon Monoxide-binding Pigment of Liver Microsomes

Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781 · see citing works

Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · see citing works

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · see citing works

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · see citing works

Resistance to fluconazole and cross‐resistance to amphotericin B in <i>Candida albicans</i> from AIDS patients caused by defective sterol Δ^5,6‐desaturation

Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · see citing works

The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans

White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292 · see citing works

Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility

Geber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., & Bennett, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2708 · Cited by 203 · see citing works

The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity

Lamb, D. C., Kelly, D. E., Schunck, W., Shyadehi, A. Z., Akhtar, M., Lowe, D. J., Baldwin, B. C., & Kelly, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5682 · Cited by 192 · see citing works

Interaction of azole antifungal antibiotics with cytochrome P -450-dependent 14α-sterol demethylase purified from Candida albicans

Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1990) · Biochemical Journal · doi:10.1042/bj2660475 · Cited by 189 · see citing works

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

Parkinson, T., Falconer, D. J., & Hitchcock, C. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1696 · Cited by 127 · see citing works

Resistance of Candida albicans to azole antifungal agents

Hitchcock, C. A. (1993) · Biochemical Society Transactions · doi:10.1042/bst0211039 · Cited by 118 · see citing works

Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment

Burgener-Kairuz, P., Zuber, J. P., Jaunin, P., Buchman, T. G., Billé, J., & Rossier, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1902-1907.1994 · Cited by 114 · see citing works

Invasive Infections Due to Candida krusei: Report of Ten Cases of Fungemia that Include Three Cases of Endophthalmitis

McQuillen, D. P., Zingman, B. S., Meunier, F., & Levitz, S. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.472 · Cited by 87 · see citing works

Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei

Fisher, M. A., Shen, S. H., Haddad, J., & Tarry, W. F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1443 · Cited by 81 · see citing works

Candida krusei Fungemia

Goldman, M., Pottage, J. C., & Weaver, D. C. (1993) · Medicine · doi:10.1097/00005792-199305000-00002 · Cited by 78 · see citing works

Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2443 · Cited by 58 · see citing works

Dimorphism-associated Variations in the Lipid Composition of Candida albicans

Ghannoum, M. A., Janini, G. M., Khamis, L., & Radwan, S. S. (1986) · Microbiology · doi:10.1099/00221287-132-8-2367 · Cited by 56 · see citing works

Origin of differences in susceptibility of Candida krusei to azole antifungal agents

Marichal, P., Gorrens, J., Coene, M. C., Jeune, L. L., & BOSSCHE, H. V. (1995) · Mycoses · doi:10.1111/j.1439-0507.1995.tb00032.x · Cited by 51 · see citing works

Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany

Zepelin, M. B., Eiffert, H., Kann, M., & Rüchel, R. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00759.x · Cited by 48 · see citing works

Variation in lipid and sterol contents inCandida albicanswhite and opaque phenotypes

Ghannoum, M. A., Swairjo, I., & Soll, D. R. (1990) · Medical Mycology · doi:10.1080/02681219080000151 · Cited by 43 · see citing works

Purification and properties of cytochrome P-450-dependent 14 α-sterol demethylase from Candida albicans

Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1989) · Biochemical Journal · doi:10.1042/bj2630573 · Cited by 37 · see citing works

Sterols of the plant pathogenic fungi Botrytis cinerea and Pyrenophora teres

Loeffler, R. S. T., & Hayes, A. L. (1990) · Phytochemistry · doi:10.1016/0031-9422(90)85250-j · Cited by 36 · see citing works

Effects of Sterol Biosynthesis Inhibitor Fungicides on Growth and Sterol Composition of Ustilago maydis, Botrytis cinerea and Pyrenophora teres

Loeffler, R. S. T., & Hayes, A. L. (1992) · Pesticide Science · doi:10.1002/ps.2780360103 · Cited by 34 · see citing works

Convenient procedure for the isolation of highly enriched, cytochrome P-450-containing microsomal fraction from Candida tropicalis

Käppeli, O., Sauer, M., & Fiechter, A. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90126-9 · Cited by 33 · see citing works

Inhibition and interaction of cytochrome P450 ofCandida kruseiwith azole antifungal drugs

Venkateswarlu, K., Denning, D. W., & Kelly, S. (1997) · Medical Mycology · doi:10.1080/02681219780000821 · Cited by 32 · see citing works

Cytochrome P-450-dependent 14 α-demethylation of lanosterol in Candida albicans

Hitchcock, C. A., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1989) · Biochemical Journal · doi:10.1042/bj2600549 · Cited by 30 · see citing works

Reference high-efficiency nonpolar packed columns for the gas—liquid chromatography of nanogram amounts of steroids part I. Retention time data

Vandenheuvel, F. A., & Court, A. S. (1968) · Journal of Chromatography A · doi:10.1016/0021-9673(68)85073-3 · Cited by 30 · see citing works

Ketoconazole-mediated growth inhibition in Botrytis cinerea and Saccharomyces cerevisiae

Quail, M. A., Arnold, A. C., Moore, D. J., Goosey, M. W., & Kelley, S. L. (1993) · Phytochemistry · doi:10.1016/s0031-9422(00)94980-x · Cited by 30 · see citing works

Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1382 · Cited by 26 · see citing works

In vitro Susceptibility of Yeast Isolates from the Blood to Fluconazole and Amphotericin B

Dermoumi, H. L. (2009) · Chemotherapy · doi:10.1159/000238950 · Cited by 25 · see citing works

Growth of Candida albicans in the presence of hydrocarbons: a correlation between sterol concentration and hydrocarbon uptake

Sorkhoh, N. A., Ghannoum, M. A., Ibrahim, A. S., Stretton, R. J., & Radwan, S. S. (1991) · Applied Microbiology and Biotechnology · doi:10.1007/bf00180579 · Cited by 16 · see citing works

Reference high-efficiency nonpolar packed columns for the gas—liquid chromatography of nanogram amounts of steroids

Vandenheuvel, F. A., & Court, A. S. (1969) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)97970-1 · Cited by 14 · see citing works

The distinction of different types of cytochromes P-450 from the yeasts Candida tropicalis and Saccharomyces uvarum

Sanglard, D., Käppeli, O., & Fiechter, A. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90075-5 · Cited by 14 · see citing works

Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance

Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,788 · see citing works

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900 · see citing works

Antifungal Drug Resistance: Molecular Mechanisms in <i>Candida albicans</i> and Beyond

Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801 · see citing works

Nosocomial fungal infections: epidemiology, diagnosis, and treatment

Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738 · see citing works

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619 · see citing works

Efflux-Mediated Antifungal Drug Resistance

Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608 · see citing works

Antifungal drug resistance of pathogenic fungi

Kontoyiannis, D. P., & Lewis, R. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08162-x · Cited by 553 · see citing works

Fluconazole resistance in &lt;em&gt;Candida&lt;/em&gt; species: a current perspective

Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542 · see citing works

Molecular basis of resistance to azole antifungals.

Lupetti, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02280-3 · Cited by 449 · see citing works

Antifungal drug resistance among <i>Candida</i> species: mechanisms and clinical impact

Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394 · see citing works

Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans

Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology · doi:10.1099/00221287-145-10-2701 · Cited by 382 · see citing works

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods

Pfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314 · see citing works

The rapid emergence of antifungal-resistant human-pathogenic fungi

Lockhart, S. R., Chowdhary, A., & Gold, J. A. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00960-9 · Cited by 315 · see citing works

Regulation of multidrug resistance in pathogenic fungi

Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · see citing works

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Pfaller, M. A., Diekema, D. J., & Sheehan, D. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.435-447.2006 · Cited by 298 · see citing works

An update on antifungal targets and mechanisms of resistance in<i>Candida</i><i>albicans</i>

Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291 · see citing works

Antifungal Resistance in Pathogenic Fungi

Perea, S. H., & Patterson, T. F. (2002) · Clinical Infectious Diseases · doi:10.1086/344058 · Cited by 286 · see citing works

T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood

Neely, L. A., Audeh, M., Phung, N. A., Min, M., Suchocki, A., Plourde, D., Blanco, M., Demas, V., Skewis, L. R., Anagnostou, T., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005377 · Cited by 273 · see citing works

Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates

Roscetto, E., Contursi, P., Vollaro, A., Fusco, S., Notomista, E., & Catania, M. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35530-0 · Cited by 272 · see citing works

Current Treatment Strategies for Disseminated Candidiasis

Spellberg, B. J., Filler, S. G., & Edwards, J. E. (2005) · Clinical Infectious Diseases · doi:10.1086/499057 · Cited by 253 · see citing works

Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens

Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230 · see citing works

Antimicrobial Peptide Synergies for Fighting Infectious Diseases

Mhlongo, J. T., Waddad, A. Y., Alberício, F., & de la Torre, B. G. (2023) · Advanced Science · doi:10.1002/advs.202300472 · Cited by 196 · see citing works

Virulence in Candida species

Haynes, K. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02237-5 · Cited by 191 · see citing works

Voriconazole: A New Triazole Antifungal

Sabo, J., & Abdel‐Rahman, S. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19237 · Cited by 184 · see citing works

Multidrug Resistance in Yeast Candida

Prasad, R., & Kapoor, K. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42005-1 · Cited by 182 · see citing works

Resistance of human fungal pathogens to antifungal drugs

Sanglard, D. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00344-2 · Cited by 178 · see citing works

Fungal–Metal Interactions: A Review of Toxicity and Homeostasis

Robinson, J. R., Isikhuemhen, O. S., & Anike, F. N. (2021) · Journal of Fungi · doi:10.3390/jof7030225 · Cited by 180 · see citing works

New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159 · see citing works

Update on Candida krusei , a potential multidrug-resistant pathogen

Jamiu, A. T., Albertyn, J., Sebolai, O. M., & Pohl, C. H. (2020) · Medical Mycology · doi:10.1093/mmy/myaa031 · Cited by 164 · see citing works

Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile

Scorzoni, L., de Lucas, M. P., Mesa-Arango, A. C., Fusco‐Almeida, A. M., Lozano, E., Cuenca‐Estrella, M., Mendes‐Giannini, M. J. S., & Zaragoza, Ó. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060047 · Cited by 150 · see citing works

Experimental Induction of Fluconazole Resistance in <i>Candida tropicalis</i> ATCC 750

Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., & Scalise, G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1578-1584.2000 · Cited by 145 · see citing works

Growth inhibition of<i>Candida</i>species and<i>Aspergillus fumigatus</i>by statins

Macreadie, I. G., Johnson, G., Schlosser, T., & Macreadie, P. I. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00370.x · Cited by 136 · see citing works

Responding to the Emergence of Antifungal Drug Resistance: Perspectives from the Bench and the Bedside

Beardsley, J., Halliday, C. L., Chen, S. C. ‐., & Sorrell, T. C. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0059 · Cited by 126 · see citing works

Antifungal drug resistance mechanisms

Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 121 · see citing works

Susceptibilities ofCandidaSpecies to Amphotericin B and Fluconazole: The Emergence of Fluconazole Resistance inCandida tropicalis

Yang, Y.-L., Ho, Y.-A., Cheng, H.-H., Ho, M., & Lo, H. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502294 · Cited by 119 · see citing works

Beach sand and the potential for infectious disease transmission: observations and recommendations

Solo‐Gabriele, H. M., Harwood, V. J., Kay, D., Fujioka, R. S., Sadowsky, M. J., Whitman, R. L., Wither, A., Caniça, M., Fonseca, R. C., Duarte, A., et al. (2015) · Journal of the Marine Biological Association of the United Kingdom · doi:10.1017/s0025315415000843 · Cited by 117 · see citing works

Fungal infections after bone marrow transplant

Wingard, J. R. (1999) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.1999.v5.pm10371357 · Cited by 109 · see citing works

Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole

Espinel-Ingroff, A., Pfaller, M. A., Bustamante, B., Canton, E., Fothergill, A., Fuller, J., Gonzalez, G. M., Lass-Flörl, C., Lockhart, S. R., Martin-Mazuelos, E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-13 · Cited by 105 · see citing works

Identification and expression of multidrug resistancerelated ABC transporter genes in Candida krusei

Katiyar, S. K., & Edlind, T. D. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.109.116 · Cited by 104 · see citing works

Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei

Das, B., Khan, M. I., Jayabalan, R., Behera, S. K., Yun, S., Tripathy, S. K., & Mishra, A. (2016) · Scientific Reports · doi:10.1038/srep36403 · Cited by 102 · see citing works

Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in <i>Candida krusei</i>

Lamping, E., Ranchod, A., Nakamura, K., Tyndall, J. D. A., Niimi, K., Holmes, A. R., Niimi, M., & Cannon, R. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01095-08 · Cited by 100 · see citing works

Emergence of Saccharomyces cerevisiae as a human pathogen

Murphy, A., & Kavanagh, K. (1999) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(99)00086-1 · Cited by 98 · see citing works

Molecular aspects of azole antifungal action and resistance

Lamb, D. C., Kelly, D. E., & Kelly, S. L. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0112 · Cited by 96 · see citing works

Species identification of medically important fungi by use of real-time LightCycler PCR

Hsu, M.-C., Chen, K.-W., Lo, H., Chen, Y., Liao, M.-H., Lin, Y., & Li, S. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05302-0 · Cited by 96 · see citing works

Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei

Fukuoka, T., Johnston, D. A., Winslow, C. A., de Groot, M. J., Burt, C., Hitchcock, C. A., & Filler, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1213-1219.2003 · Cited by 97 · see citing works

Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans

Favre, B., Ryder, N. S., & Didmon, M. P. (1999) · Microbiology · doi:10.1099/00221287-145-10-2715 · Cited by 94 · see citing works

Isavuconazole

Pettit, N. N., & Carver, P. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015581679 · Cited by 86 · see citing works

Invasive Candidiasis: An Overview from Taiwan

Ruan, S., & Hsueh, P. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60091-7 · Cited by 85 · see citing works

Antifungal resistance in non- albicans Candida species

Collin, B. A., Clancy, C. J., & Nguyen, M. H. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0059 · Cited by 82 · see citing works

Retrospective suspect screening reveals previously ignored antibiotics, antifungal compounds, and metabolites in Bangladesh surface waters

Angeles, L. F., Islam, S., Aldstadt, J., Saqeeb, K. N., Alam, M., Khan, M. A., Johura, F., Ahmed, S. I., & Aga, D. S. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.136285 · Cited by 80 · see citing works

Time to positivity of blood cultures of different Candida species causing fungaemia

Lai, C., Wang, C.-Y., Liu, W., Huang, Y., & Hsueh, P. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.038166-0 · Cited by 75 · see citing works

Diversity and antifungal susceptibility of yeasts from tropical freshwater environments in Southeastern Brazil

Medeiros, A. O., Kohler, L. M., Hamdan, J. S., Missagia, B. D. S., Barbosa, F. A. R., & Rosa, C. A. (2008) · Water Research · doi:10.1016/j.watres.2008.05.026 · Cited by 71 · see citing works

Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults

Bow, E. J., Evans, G. A., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R. P., Shafran, S. D., Sheppard, D. C., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 68 · see citing works

Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients

Rosa, G. R. D. L., Champlin, R. E., & Kontoyiannis, D. P. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.00010.x · Cited by 67 · see citing works

Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006

Yang, Y.-L., Wang, A.-H., Wang, C., Cheng, W.-T., Li, S., & Lo, H. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.01.011 · Cited by 66 · see citing works

&lt;p&gt;In vitro Antifungal Effects of Berberine Against&lt;em&gt; Candida&lt;/em&gt; spp. In Planktonic and Biofilm Conditions&lt;/p&gt;

Xie, Y., Liu, X., & Zhou, P. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s230857 · Cited by 63 · see citing works

The value of amphotericin B in the treatment of invasive fungal infections

Klepser, M. E. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.08.005 · Cited by 63 · see citing works

Antifungal Prophylaxis in Liver Transplantation: A Systematic Review and Network Meta-Analysis

Evans, J., Morris, P. J., & Knight, S. R. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12925 · Cited by 63 · see citing works

Enhanced antifungal activity of fluconazole conjugated with Cu-Ag-ZnO nanocomposite

Ghosh, M., Mandal, S., Roy, A., Chakrabarty, S., Chakrabarti, G., & Pradhan, S. K. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110160 · Cited by 61 · see citing works

Antifungal Resistance Among Candida Species

Klepser, M. E. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.12.124s.34511 · Cited by 60 · see citing works

Antifungal drugs and resistance: Current concepts

Nigam, P. K. (2015) · Our Dermatology Online · doi:10.7241/ourd.20152.58 · Cited by 60 · see citing works

Fluconazole resistance mechanisms inCandida krusei: The contribution of efflux-pumps

Guinea, J., Sánchez-Somolinos, M., Cuevas, Ó., Peláez, T., & Bouza, E. (2006) · Medical Mycology · doi:10.1080/13693780600561544 · Cited by 58 · see citing works

Azole‐resistant Candida spp. – emerging pathogens?

Tobudic, S., Kratzer, C., & Presterl, E. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02146.x · Cited by 57 · see citing works

Fruits as the vehicle of drug resistant pathogenic yeasts

Lo, H., Tsai, S.-H., Chu, W.-L., Chen, Y.-Z., Zhou, Z.-L., Chen, H.-F., Lee, C.-F., & Yang, Y.-L. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.06.005 · Cited by 53 · see citing works

Colonization of Human Immunodeficiency Virus-Infected Outpatients in Taiwan with Candida Species

Hung, C., Yang, Y.-L., Lauderdale, T.-L. Y., McDonald, L. C., Hsiao, C., Cheng, H.-H., Ho, Y.-A., & Lo, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1600-1603.2005 · Cited by 52 · see citing works

Development of Antifungal Therapies Using Nanomaterials

Niemirowicz, K., Durnaś, B., Piktel, E., & Bucki, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0052 · Cited by 51 · see citing works

Candida albicans and Candida tropicalis in Oral Candidosis: Quantitative Analysis, Exoenzyme Activity, and Antifungal Drug Sensitivity

da Costa, K. R. C., Ferreira, J. C., Komesu, M. C., & Cândido, R. C. (2008) · Mycopathologia · doi:10.1007/s11046-008-9154-8 · Cited by 50 · see citing works

Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002

Yang, Y.-L., Li, S.-Y., Cheng, H.-H., & Lo, H. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.11.004 · Cited by 49 · see citing works

Emerging echinocandins for treatment of invasive fungal infections

Turner, M., Drew, R. H., & Perfect, J. R. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.2.231 · Cited by 49 · see citing works

Antifungal drug resistance: does it matter?

Rogers, T. R. (2002) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(02)90154-2 · Cited by 48 · see citing works

Emerging Issues in Antifungal Resistance

Perfect, J. R., & Ghannoum, M. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.05.003 · Cited by 44 · see citing works

Past, Present, and Future of Antifungal Drug Development

Shukla, P. K., Singh, P., Yadav, R. K., Pandey, S., & Bhunia, S. S. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_4 · Cited by 46 · see citing works

Emerging fungal resistance

Baddley, J. W., & Moser, S. A. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.05.003 · Cited by 46 · see citing works

Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors

Willers, C., Wentzel, J. F., Plessis, D., Gouws, C., & Hamman, J. H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1265105 · Cited by 45 · see citing works

Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.

Yang, Y.-L., Cheng, H.-H., Ho, Y.-A., Hsiao, C., & Lo, H. (2003) · PubMed · Cited by 45 · see citing works

Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis

Rad, K., Falahati, M., Roudbary, M., Farahyar, S., & Nami, S. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.4.24 · Cited by 46 · see citing works

Increased coverage and high confidence in suspect screening of emerging contaminants in global environmental samples

Angeles, L. F., Singh, R. R., Vikesland, P. J., & Aga, D. S. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.125369 · Cited by 42 · see citing works

Candida krusei: biotechnological potentials and concerns about its safety

Yadav, J. S. S., Bezawada, J., Yan, S., Tyagi, R. D., & Surampalli, R. Y. (2012) · Canadian Journal of Microbiology · doi:10.1139/w2012-077 · Cited by 42 · see citing works

In VivoandIn VitroAcquisition of Resistance to Voriconazole by Candida krusei

Ricardo, E., Miranda, I. M., Faria‐Ramos, I., Silva, R. M., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02603-14 · Cited by 40 · see citing works

DNA microarray-based identification of bacterial and fungal pathogens in bloodstream infections

Yoo, S. M., Choi, J. Y., Yun, J. K., Choi, J., Shin, S., Lee, K., Kim, J. M., & Lee, S. Y. (2009) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2009.09.003 · Cited by 40 · see citing works

Conventional and alternative antifungal therapies to oral candidiasis

Aníbal, P. C., Sardi, J. D. C. O., Peixoto, I. T. A., Moraes, J. J. D. C., & Höfling, J. F. (2010) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822010000400001 · Cited by 39 · see citing works

Genome-scale metabolic reconstruction of the non-model yeast Issatchenkia orientalis SD108 and its application to organic acids production

Suthers, P. F., Dinh, H. V., Fatma, Z., Shen, Y., Chan, S. H. J., Rabinowitz, J. D., Zhao, H., & Maranas, C. D. (2020) · Metabolic Engineering Communications · doi:10.1016/j.mec.2020.e00148 · Cited by 38 · see citing works

The pathophysiology and treatment of Candida sepsis

Spellberg, B. J., & Edwards, J. E. (2002) · Current Infectious Disease Reports · doi:10.1007/s11908-002-0005-3 · Cited by 37 · see citing works

Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience

Choi, H. K., Jeong, S. J., Lee, H. S., Chin, B. S., Choi, S. H., Han, S. H., Kim, M. S., Kim, C. O., Choi, J. Y., Song, Y. G., et al. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.3.263 · Cited by 36 · see citing works

Antifungal amphiphilic kanamycins: new life for an old drug

Subedi, Y. P., Alfindee, M. N., Takemoto, J. Y., & Chang, C. T. (2018) · MedChemComm · doi:10.1039/c8md00155c · Cited by 34 · see citing works

Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts

Stavrou, A. A., Hansen, A. P., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2020) · Medical Mycology · doi:10.1093/mmy/myaa005 · Cited by 35 · see citing works

Candidemia in Burn Patients: Figures and Facts

Pedrosa, A. F., & Rodrigues, A. G. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f2d4fb · Cited by 34 · see citing works

Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.

Alp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32 · see citing works

Dynamics ofin vitro acquisition of resistance byCandida parapsilosisto different azoles

Silva, A. P., Costa‐de‐Oliveira, S., Silva-Dias, A., Pina‐Vaz, C., & Rodrigues, A. G. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00508.x · Cited by 32 · see citing works

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan

Yang, Y.-L., Li, S., Cheng, H.-H., & Lo, H. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-99 · Cited by 32 · see citing works

Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic Procedures

Majoros, L., Kardos, G., Belák, Á., Maráz, A., Asztalos, L., Csánky, E., Barta, Z., & Szabó, B. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5250-5253.2003 · Cited by 32 · see citing works

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei

He, X., Zhao, M., Chen, J., Wu, R., Zhang, J., Cui, R., Jiang, Y., Chen, J., Cao, X., Xing, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136185 · Cited by 31 · see citing works

Do all candidemic patients need an ophthalmic examination?

Vinikoor, M. J., Zoghby, J., Cohen, K. L., & Tucker, J. D. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.12.014 · Cited by 31 · see citing works

Comparison of Two Commercially Available qPCR Kits for the Detection of Candida auris

Sattler, J., Noster, J., Brunke, A., Plum, G., Wiegel, P., Kurzai, O., Meis, J. F. G. M., & Hamprecht, A. G. (2021) · Journal of Fungi · doi:10.3390/jof7020154 · Cited by 31 · see citing works

Microbiological Screening of Irish Patients with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Reveals Persistence of Candida albicans Strains, Gradual Reduction in Susceptibility to Azoles, and Incidences of Clinical Signs of Oral Candidiasis without Culture Evidence

McManus, B. A., McGovern, E., Moran, G. P., Healy, C. M., Nunn, J., Fleming, P., Costigan, C., Sullivan, D. J., & Coleman, D. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00026-11 · Cited by 30 · see citing works

A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance

Erum, R., Samad, F., Khan, A., & Kazmi, S. U. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02045-6 · Cited by 29 · see citing works

Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their In Vitro Interactions Against Candida Isolates from Neonatal Oral Thrush

Khalandi, H., Masoori, L., Farahyar, S., Delbandi, A. A., Raiesi, O., Farzanegan, A., Khalandi, G., Mahmoudi, S., Erfanirad, T., & Falahati, M. (2020) · Assay and Drug Development Technologies · doi:10.1089/adt.2020.971 · Cited by 28 · see citing works

Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran

Maheronnaghsh, M., Fatahinia, M., Dehghan, P., & Teimoori, A. (2020) · Advanced Biomedical Research · doi:10.4103/abr.abr_214_19 · Cited by 28 · see citing works

Candidemia in Children

Silvester, E. J., Watanabe, M., Pittet, L. F., Boast, A., Bryant, P. A., Haeusler, G. M., Daley, A. J., Curtis, N. C., & Gwee, A. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003082 · Cited by 27 · see citing works

Distribution and antifungal susceptibility ofCandidaspecies isolated from different age populations in Taiwan

Yang, Y.-L., Cheng, H.-H., & Lo, H. (2006) · Medical Mycology · doi:10.1080/13693780500401213 · Cited by 28 · see citing works

Inhibition and interaction of cytochrome P450 ofCandida kruseiwith azole antifungal drugs

Venkateswarlu, K., Denning, D. W., & Kelly, S. (1997) · Medical Mycology · doi:10.1080/02681219780000821 · Cited by 32 · see citing works

Fluconazole resistance mechanisms inCandida krusei: The contribution of efflux-pumps

Guinea, J., Sánchez-Somolinos, M., Cuevas, Ó., Peláez, T., & Bouza, E. (2006) · Medical Mycology · doi:10.1080/13693780600561544 · Cited by 58 · see citing works

Short Communication Fluconazole resistance mechanisms in Candida krusei: The contribution of efflux-pumps

Guinea, J., Cuevas, O., & Bouza, E. (2016)

Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2443 · Cited by 58 · see citing works

Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei

Fukuoka, T., Johnston, D. A., Winslow, C. A., de Groot, M. J., Burt, C., Hitchcock, C. A., & Filler, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1213-1219.2003 · Cited by 97 · see citing works